Valuation: Cochlear Limited

Capitalization 12.1B 8.54B 7.35B 6.67B 6.39B 11.68B 788B 78.33B 31.36B 376B 32.08B 31.39B 1,342B P/E ratio 2026 *
33.3x
P/E ratio 2027 * 27x
Enterprise value 11.85B 8.37B 7.19B 6.53B 6.26B 11.43B 771B 76.69B 30.71B 368B 31.4B 30.73B 1,314B EV / Sales 2026 *
4.87x
EV / Sales 2027 * 4.43x
Free-Float
99.53%
Yield 2026 *
2.38%
Yield 2027 * 2.68%
1 day-0.45%
1 week-6.09%
Current month-7.04%
1 month-28.85%
3 months-32.06%
6 months-38.08%
Current year-29.03%
1 week 185
Extreme 185
203.7
1 month 185
Extreme 185
258.48
Current year 185
Extreme 185
278.35
1 year 185
Extreme 185
319.56
3 years 185
Extreme 185
350.31
5 years 178.54
Extreme 178.545
350.31
10 years 98.47
Extreme 98.47
350.31
Manager TitleAgeSince
Chief Executive Officer - 03/01/2018
Chief Tech/Sci/R&D Officer - 01/02/2023
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 58 21/08/2021
Director/Board Member - 14/11/2017
Director/Board Member 69 13/12/2016
Change 5d. change 1-year change 3-years change Capi.($)
-0.45%-6.09%-29.04%-17.14% 8.58B
-2.52%-7.32%-29.20%-34.61% 18.02B
-4.34%-3.85%-33.13%-21.49% 15.52B
-0.26%+3.40% - - 4.32B
-2.50%-2.65%-4.23%-11.45% 2B
-0.30%-7.19%-38.75%-51.35% 1.59B
-4.01%-5.58%+11.22%-40.17% 1.58B
+1.78%-1.38%+47.68%+83.07% 673M
-16.88%-26.86%-4.30% - 266M
+0.65%+1.22%-32.17%+91.79% 321M
Average -2.92%-5.43%-12.44%-0.17% 5.29B
Weighted average by Cap. -2.58%-1.63%-27.22%-24.58%

Financials

2026 *2027 *
Net sales 2.43B 1.72B 1.48B 1.34B 1.29B 2.35B 158B 15.76B 6.31B 75.58B 6.45B 6.31B 270B 2.67B 1.88B 1.62B 1.47B 1.41B 2.57B 174B 17.26B 6.91B 82.78B 7.07B 6.92B 296B
Net income 350M 247M 212M 193M 185M 338M 22.78B 2.26B 907M 10.86B 927M 907M 38.79B 443M 313M 269M 244M 234M 428M 28.85B 2.87B 1.15B 13.76B 1.17B 1.15B 49.14B
Net Debt -254M -179M -154M -140M -134M -245M -16.51B -1.64B -657M -7.87B -672M -658M -28.11B -288M -203M -175M -159M -152M -278M -18.74B -1.86B -746M -8.94B -763M -747M -31.92B
Logo Cochlear Limited
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services, and Acoustics. Cochlear Implants segment offers Cochlear implant systems. Services segment offers sound processor upgrades, accessories and other. Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Its Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Employees
5,500
Date Price Change Volume
05/03/26 185.00 $ -0.45% 282,700
04/03/26 185.83 $ -3.53% 330,168
03/03/26 192.62 $ -1.57% 200,340
02/03/26 195.70 $ -1.66% 189,324
27/02/26 199.01 $ +0.17% 571,620
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
185.83AUD
Average target price
250.59AUD
Spread / Average Target
+34.85%

Quarterly revenue - Rate of surprise